Biotech and pharmaceutical investors, among others, need to watch out for the way firms treat the cost of developing new products, as this can have a big impact on a firm’s results. In his fifth video in the ‘cooking the books’ series, Tim Bennett explains how.

Pick up two sets of accounts for similar firms and you may find radically different numbers. Tim Bennett explains why this happens, and what you can do about it.